|
CA672478A
(en)
|
|
1963-10-15 |
Heim Roger |
Psilocybin and psilocin
|
|
GB911946A
(en)
|
1958-02-21 |
1962-12-05 |
Sandoz Ltd |
Psilocybin and psilocin and processes for their preparation
|
|
LU36879A1
(enExample)
|
1958-02-21 |
|
|
|
|
US3075992A
(en)
|
1958-09-12 |
1963-01-29 |
Sandoz Ltd |
Esters of indoles
|
|
NL121067C
(enExample)
|
1958-09-12 |
|
|
|
|
US3192111A
(en)
*
|
1959-02-16 |
1965-06-29 |
Sandoz Ltd |
Method of inducing therapeutic tranquilization with psilocybin and psilocin
|
|
IE24138L
(en)
|
1959-02-18 |
1959-08-21 |
Sandoz Ag |
Psilocybin and psilocin
|
|
JPS5576859A
(en)
|
1978-12-01 |
1980-06-10 |
Fujimoto Seiyaku Kk |
Novel preparation of 4-hydroxyindole
|
|
JPS5728046A
(en)
|
1980-07-28 |
1982-02-15 |
Nissan Chem Ind Ltd |
Preparation of 4-substituted indole
|
|
US4499096A
(en)
|
1983-11-18 |
1985-02-12 |
Lotsof Howard S |
Rapid method for interrupting the narcotic addiction syndrome
|
|
EP0152379A3
(de)
|
1984-02-15 |
1986-10-29 |
Ciba-Geigy Ag |
Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
|
|
US4721612A
(en)
|
1984-04-12 |
1988-01-26 |
The Liposome Company, Inc. |
Steroidal liposomes
|
|
IL76591A0
(en)
|
1984-10-05 |
1986-02-28 |
Bioferon Biochem Substanz |
Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
|
|
US5785989A
(en)
|
1985-05-01 |
1998-07-28 |
University Utah Research Foundation |
Compositions and methods of manufacturing of oral dissolvable medicaments
|
|
US4587243A
(en)
|
1985-07-15 |
1986-05-06 |
Lotsof Howard S |
Rapid method for interrupting the cocaine and amphetamine abuse syndrome
|
|
DE3689927T3
(de)
|
1985-10-04 |
1998-10-22 |
South African Inventions |
Reagens und Verfahren.
|
|
US5725871A
(en)
|
1989-08-18 |
1998-03-10 |
Danbiosyst Uk Limited |
Drug delivery compositions comprising lysophosphoglycerolipid
|
|
JP2758985B2
(ja)
|
1989-09-05 |
1998-05-28 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション |
親油性薬剤の非侵襲性用量対効果式投与のための方法及び組成物
|
|
US5629307A
(en)
|
1989-10-20 |
1997-05-13 |
Olney; John W. |
Use of ibogaine in reducing excitotoxic brain damage
|
|
US5935925A
(en)
|
1990-05-08 |
1999-08-10 |
Synaptic Pharmaceutical Corporation |
Methods of treating migraine and compounds useful for such methods
|
|
US5626863A
(en)
|
1992-02-28 |
1997-05-06 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
|
AU665933B2
(en)
|
1990-10-19 |
1996-01-25 |
New York University |
A method for transplanting cells into the brain and therapeutic uses therefor
|
|
US5827819A
(en)
|
1990-11-01 |
1998-10-27 |
Oregon Health Sciences University |
Covalent polar lipid conjugates with neurologically active compounds for targeting
|
|
FR2675504B1
(fr)
|
1991-04-16 |
1995-01-27 |
Delalande Sa |
Derives d'aryl-3 oxazolidinone, leur procede de preparation et leur application en therapeutique.
|
|
US5468486A
(en)
|
1992-01-21 |
1995-11-21 |
The University Of Tennessee Research Corporation |
Vaccine containing a protein alkaloid conjugate for the treatment of fescue toxicosis
|
|
CA2094217A1
(en)
|
1992-04-17 |
1993-10-18 |
Yasutaka Igari |
Transmucosal therapeutic composition
|
|
US5871710A
(en)
|
1992-09-04 |
1999-02-16 |
The General Hospital Corporation |
Graft co-polymer adducts of platinum (II) compounds
|
|
US5573776A
(en)
|
1992-12-02 |
1996-11-12 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
|
PT628042E
(pt)
|
1992-12-24 |
2002-01-30 |
Pharmacia & Upjohn Spa |
Derivados de ergolina serotoninergicos
|
|
ES2068762B1
(es)
|
1993-07-21 |
1995-12-01 |
Lipotec Sa |
Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
|
|
US5545617A
(en)
|
1993-11-12 |
1996-08-13 |
The Schepens Eye Research Institute, Inc. |
Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
|
|
US20060019963A1
(en)
|
1994-06-17 |
2006-01-26 |
Smithkline Beecham Corporation |
Compounds
|
|
WO1996003127A1
(en)
|
1994-07-25 |
1996-02-08 |
Nda International, Inc. |
A method of treating chemical dependency in mammals and a composition therefor
|
|
US5874477A
(en)
|
1994-08-12 |
1999-02-23 |
The University Of Hawaii |
Method of treatment for malaria utilizing serotonin receptor ligands
|
|
US5696125A
(en)
|
1995-02-24 |
1997-12-09 |
Research Foundation Of The State University Of New York |
Substance abuse-induced hemorrhagic stoke in an animal model
|
|
US5643586A
(en)
|
1995-04-27 |
1997-07-01 |
Perricone; Nicholas V. |
Topical compositions and methods for treatment of skin damage and aging using catecholamines and related compounds
|
|
US5942241A
(en)
|
1995-06-09 |
1999-08-24 |
Euro-Celtique, S.A. |
Formulations and methods for providing prolonged local anesthesia
|
|
US5879690A
(en)
|
1995-09-07 |
1999-03-09 |
Perricone; Nicholas V. |
Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
|
|
DE19542281C2
(de)
|
1995-11-14 |
1997-12-04 |
Boehringer Ingelheim Kg |
Verwendung von Epinastin für die Behandlung der Migräne
|
|
FR2744361B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744363B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de thiazolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744364B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application d'ureidoacetamides a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744362B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
CA2250042A1
(en)
|
1996-03-25 |
1997-10-02 |
Eli Lilly And Company |
Treating pain using a synergistic combination of an atypical antipsychotic and a drug used in treatment of pain
|
|
TW448171B
(en)
|
1996-06-06 |
2001-08-01 |
Yamanouchi Pharma Co Ltd |
Imidazole-substituted quinoxalinedione derivatives
|
|
AU3290397A
(en)
|
1996-06-10 |
1998-01-07 |
Depomed, Inc. |
Gastric-retentive oral controlled drug delivery system with enhanced retention properties
|
|
US5914129A
(en)
|
1996-07-23 |
1999-06-22 |
Mauskop; Alexander |
Analgesic composition for treatment of migraine headaches
|
|
US5902815A
(en)
|
1996-09-03 |
1999-05-11 |
Washington University |
Use of 5HT-2A serotonin agonists to prevent adverse effects of NMDA receptor hypofunction
|
|
US5958919A
(en)
|
1996-09-20 |
1999-09-28 |
Washington University |
Treatment of presymptomatic alzheimer's disease to prevent neuronal degeneration
|
|
US5891885A
(en)
|
1996-10-09 |
1999-04-06 |
Algos Pharmaceutical Corporation |
Method for treating migraine
|
|
US6479074B2
(en)
|
1996-10-24 |
2002-11-12 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
|
AU743788B2
(en)
|
1997-05-07 |
2002-02-07 |
Unimed Pharmaceuticals, Inc. |
Method of improving disturbed behavior and elevating mood in humans
|
|
US5804592A
(en)
|
1997-05-30 |
1998-09-08 |
Unimed Pharmaceuticals, Inc. |
Method for improving disturbed behavior and elevating mood in humans
|
|
WO1998059234A1
(en)
|
1997-06-24 |
1998-12-30 |
The University Of Wyoming |
Method and apparatus for detection of a controlled substance
|
|
GB9715082D0
(en)
|
1997-07-17 |
1997-09-24 |
Scherer Ltd R P |
Treatment of attention deficit hyperactivity disorder and narcolepsy
|
|
US7799337B2
(en)
|
1997-07-21 |
2010-09-21 |
Levin Bruce H |
Method for directed intranasal administration of a composition
|
|
US20010004644A1
(en)
|
1997-07-21 |
2001-06-21 |
Levin Bruce H. |
Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
|
|
WO1999009828A1
(en)
|
1997-08-25 |
1999-03-04 |
Pentech Pharmaceuticals, Inc. |
Method for amelioration of social phobia
|
|
ES2224430T3
(es)
|
1997-09-04 |
2005-03-01 |
Novoneuron Inc |
Noribogaina en el tratamiento del dolor y de la toxicomania.
|
|
US7220737B1
(en)
|
1997-09-04 |
2007-05-22 |
Novoneuron, Inc |
Noribogaine in the treatment of pain and drug addiction
|
|
DE19738855C2
(de)
|
1997-09-05 |
2001-01-04 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht
|
|
US20030077227A1
(en)
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
|
US5922341A
(en)
|
1997-10-28 |
1999-07-13 |
Vivus, Incorporated |
Local administration of pharmacologically active agents to treat premature ejaculation
|
|
US6037346A
(en)
|
1997-10-28 |
2000-03-14 |
Vivus, Inc. |
Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
AU740758B2
(en)
|
1997-10-28 |
2001-11-15 |
Vivus, Inc. |
Treatment of female sexual dysfunction
|
|
US6228864B1
(en)
|
1997-10-28 |
2001-05-08 |
Vivus, Inc. |
Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
|
|
ITTO980264A1
(it)
|
1998-03-26 |
1999-09-26 |
Silvio Rossi |
Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica
|
|
EP1089736A2
(en)
|
1998-06-22 |
2001-04-11 |
Queen's University At Kingston |
Method and compositions for the treatment or amelioration of female sexual dysfunction
|
|
WO2000003746A2
(en)
|
1998-07-14 |
2000-01-27 |
The Brigham And Women's Hospital, Inc. |
Upregulation of type iii endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
|
|
WO2000003679A2
(en)
|
1998-07-14 |
2000-01-27 |
Adams Food Ltd. |
Nutritionally active composition for hardening fingernails
|
|
CA2337507A1
(en)
|
1998-07-16 |
2000-01-27 |
Massachusetts Institute Of Technology |
Composition for treatment of stress
|
|
CA2338326A1
(en)
|
1998-07-31 |
2000-02-10 |
Seth Lederman |
Use of moclobemide and metabolites for treating and preventing substance abuse
|
|
AU755119B2
(en)
|
1998-09-18 |
2002-12-05 |
Alcon Laboratories, Inc. |
Serotonergic 5HT2 agonists for treating glaucoma
|
|
US20060025387A1
(en)
|
1998-12-23 |
2006-02-02 |
Cytoscan Sciences Llc |
Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
|
|
JP2002535353A
(ja)
|
1999-01-29 |
2002-10-22 |
ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク |
医薬品組成物
|
|
NZ513643A
(en)
|
1999-02-24 |
2005-04-29 |
Univ Cincinnati |
Use of sulfamate derivatives for treating impulse control disorders
|
|
WO2000056403A1
(en)
|
1999-03-19 |
2000-09-28 |
The Brigham And Women's Hospital, Inc. |
UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
|
|
WO2000059481A1
(en)
|
1999-04-06 |
2000-10-12 |
Pharmaquest Ltd. |
PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF d-threo-METHYLPHENIDATE AND A SECOND CNS STIMULANT
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
IL145451A0
(en)
|
1999-04-07 |
2002-06-30 |
Pfizer Prod Inc |
Use of cyp2d6 inhibitors in combination therapies
|
|
US6495498B2
(en)
|
1999-05-27 |
2002-12-17 |
Johnson & Johnson Consumer Companies, Inc. |
Detergent compositions with enhanced depositing, conditioning and softness capabilities
|
|
US6126924A
(en)
|
1999-05-27 |
2000-10-03 |
Scales-Medeiros; Virginia A. |
Light responsive self-tanning products and methods for use
|
|
US6489341B1
(en)
|
1999-06-02 |
2002-12-03 |
Sepracor Inc. |
Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
|
|
US20080103179A1
(en)
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
|
US6500459B1
(en)
|
1999-07-21 |
2002-12-31 |
Harinderpal Chhabra |
Controlled onset and sustained release dosage forms and the preparation thereof
|
|
CA2382666A1
(en)
|
1999-08-23 |
2001-03-01 |
The Administrators Of The Tulane Educational Fund |
Modulation of the blood-brain barrier transporter for leptin
|
|
US6204245B1
(en)
|
1999-09-17 |
2001-03-20 |
The Regents Of The University Of California |
Treatment of narcolepsy with immunosuppressants
|
|
WO2001026642A2
(en)
|
1999-10-08 |
2001-04-19 |
Joyce Corinne Bechthold |
Methods and compositions for treating neurobehavioral disorders
|
|
ES2162746B1
(es)
|
1999-10-21 |
2003-02-16 |
Lipotec Sa |
Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion.
|
|
US6693135B2
(en)
|
2000-01-10 |
2004-02-17 |
Nexmed (Holdings) Incorporated |
Prostaglandin compositions and methods of treatment for male erectile dysfunction
|
|
US20030096831A1
(en)
|
2000-01-18 |
2003-05-22 |
Stone Richard A. |
Ocular growth and nicotinic antagonists
|
|
WO2001052832A1
(en)
|
2000-01-18 |
2001-07-26 |
Valley Forge Pharmaceuticals, Inc. |
Ocular growth and nicotinic antagonists
|
|
FR2804603B1
(fr)
|
2000-02-04 |
2004-01-23 |
Rhodia Chimie Sa |
Procede continu pour formuler sous forme de granules une ou plusieurs matieres actives pharmaceutiques
|
|
US20020015730A1
(en)
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
|
AU2001243369A1
(en)
|
2000-03-14 |
2001-09-24 |
Massachusetts Institute Of Technology |
Composition and method to treat weight gain and obesity attributable to psychotropic drugs
|
|
AU2001247767A1
(en)
|
2000-03-27 |
2001-10-08 |
Pe Corporation (Ny) |
Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
|
|
DE10014588A1
(de)
|
2000-03-27 |
2001-10-04 |
Basf Ag |
Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
|
|
US6380176B2
(en)
|
2000-03-28 |
2002-04-30 |
Ajinomoto Co., Inc. |
Method for inhibiting non-intentional behavior with a running neuron inhibitory substance
|
|
DE10018834A1
(de)
|
2000-04-15 |
2001-10-25 |
Lohmann Therapie Syst Lts |
Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
|
|
AU6106801A
(en)
|
2000-04-28 |
2001-11-12 |
Gary W. Neal |
Trans-clitoral administration of therapy
|
|
AU5967101A
(en)
|
2000-05-10 |
2001-11-20 |
Rtp Pharma Inc |
Media milling
|
|
US20070059367A1
(en)
|
2000-06-06 |
2007-03-15 |
Cherukuri S R |
Drug Delivery System and Associated Methods
|
|
US20020044962A1
(en)
|
2000-06-06 |
2002-04-18 |
Cherukuri S. Rao |
Encapsulation products for controlled or extended release
|
|
US20020019421A1
(en)
|
2000-07-05 |
2002-02-14 |
Roni Biberman |
Compositions and therapy for substance addiction
|
|
DE60143058D1
(de)
|
2000-07-19 |
2010-10-21 |
Univ Northwest |
Transport von nukleinsäuresubstanzen
|
|
CA2422730A1
(en)
|
2000-09-19 |
2002-03-28 |
Microbia, Inc. |
Modulation of secondary metabolite production by zinc binuclear cluster proteins
|
|
US9399050B2
(en)
|
2000-10-04 |
2016-07-26 |
Paul Edward Stamets |
Controlling insects and arthropods using preconidial mycelium and extracts of preconidial mycelium from entomopathogenic fungi
|
|
US9474776B2
(en)
|
2000-10-04 |
2016-10-25 |
Paul Edward Stamets |
Integrative fungal solutions for protecting bees
|
|
US20070100000A1
(en)
|
2000-11-01 |
2007-05-03 |
Epstein Mel H |
Methods of providing neuroprotection
|
|
US20030119884A1
(en)
|
2000-11-01 |
2003-06-26 |
Epstein Mel H. |
Methods and compositions for regulating memory consolidation
|
|
CA2359812C
(en)
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
|
AR031473A1
(es)
|
2000-11-20 |
2003-09-24 |
Lundbeck & Co As H |
Intensificadores de gaba en el tratamiento de enfermedades relacionadas con una reducida actividad neuroesteroide
|
|
US6495154B1
(en)
|
2000-11-21 |
2002-12-17 |
Vivus Inc. |
On demand administration of clomipramine and salts thereof to treat premature ejaculation
|
|
IL139975A0
(en)
|
2000-11-29 |
2002-02-10 |
Univ Ramot |
Anti proliferative drugs
|
|
KR20030059290A
(ko)
|
2000-11-30 |
2003-07-07 |
화이자 프로덕츠 인코포레이티드 |
Ｇａｂａ 작용제 및 소르비톨 데하이드로게나제 억제제의혼합물
|
|
AP2001002359A0
(en)
|
2000-11-30 |
2001-12-31 |
Pfizer Prod Inc |
Combination of gaba agonists and aldose reductase inhibitors.
|
|
US20050176790A1
(en)
|
2001-02-28 |
2005-08-11 |
Johannes Bartholomaus |
Pharmaceutical salts
|
|
US20020137785A1
(en)
|
2001-03-26 |
2002-09-26 |
George Kindness |
Inflammatory mechanism modulator composition and methods with anti-asthmatic properties
|
|
US20050096396A1
(en)
|
2002-03-28 |
2005-05-05 |
Emory University |
Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
|
|
WO2002078643A2
(en)
|
2001-03-30 |
2002-10-10 |
Philadelphia Health And Education Corporation |
Immunomodulation and effect on cell processes relating to serotonin family receptors
|
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
|
AU2002303577B2
(en)
|
2001-05-04 |
2006-06-08 |
Merck & Co., Inc. |
Method and compositions for treating migraines
|
|
US7766013B2
(en)
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
|
US20040023952A1
(en)
|
2001-06-20 |
2004-02-05 |
Leventhal Audie G. |
Enhanced brain function by gaba-ergic stimulation
|
|
WO2003016903A2
(de)
|
2001-08-20 |
2003-02-27 |
Walter Pils |
Vorrichtung und verfahren zum nachweis eines analyten
|
|
US6541043B2
(en)
|
2001-08-28 |
2003-04-01 |
Dexgen Pharmaceuticals, Inc. |
Method and synergistic composition for treating attention deficit/hyperactivity disorder
|
|
US20030099711A1
(en)
|
2001-08-29 |
2003-05-29 |
David Meadows |
Sustained release preparations
|
|
EP1425040A2
(en)
|
2001-09-14 |
2004-06-09 |
Cytos Biotechnology AG |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
EP1450856B1
(en)
|
2001-09-14 |
2009-11-11 |
Cytos Biotechnology AG |
Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
|
|
US7544681B2
(en)
|
2001-09-27 |
2009-06-09 |
Ramot At Tel Aviv University Ltd. |
Conjugated psychotropic drugs and uses thereof
|
|
BR0212824A
(pt)
|
2001-09-27 |
2004-10-13 |
Pharmacia Ab |
Composição farmacêutica
|
|
US6592901B2
(en)
|
2001-10-15 |
2003-07-15 |
Hercules Incorporated |
Highly compressible ethylcellulose for tableting
|
|
US20060264508A1
(en)
|
2001-10-16 |
2006-11-23 |
Stone Richard A |
Modulation of ocular growth and myopia by gaba drugs
|
|
US20030082225A1
(en)
|
2001-10-19 |
2003-05-01 |
Mason Paul Arthur |
Sterile, breathable patch for treating wound pain
|
|
US7045543B2
(en)
|
2001-11-05 |
2006-05-16 |
Enzrel Inc. |
Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
|
|
AU2002340439A1
(en)
|
2001-11-09 |
2003-05-26 |
Chiron Corporation |
Method of vaccinating a human patient to prevent metastatic tumors
|
|
GB0127832D0
(en)
|
2001-11-20 |
2002-01-09 |
Jagotec Ag |
Method for the preparation of pharmaceutical nanosuspensions
|
|
AU2002352878B2
(en)
|
2001-11-27 |
2007-11-22 |
Merck Sharp & Dohme Corp. |
2-Aminoquinoline compounds
|
|
EP1451156A4
(en)
|
2001-11-27 |
2005-05-25 |
Merck & Co Inc |
4-AMINOCHINOLINVERBINDUNGEN
|
|
AU2002219964A1
(en)
|
2001-11-29 |
2003-06-17 |
Penwest Pharmaceutical Company |
Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
|
|
US20030171435A1
(en)
|
2002-01-23 |
2003-09-11 |
Drug Abuse Sciences, Inc. |
New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them
|
|
US7241797B2
(en)
|
2002-01-23 |
2007-07-10 |
University Of Cincinnati |
Method of increasing milk production
|
|
BR0307593A
(pt)
|
2002-02-07 |
2005-02-01 |
Pharmacia Corp |
Comprimidos farmacêuticos
|
|
CA2474190A1
(en)
|
2002-02-07 |
2003-08-14 |
Pharmacia Corporation |
Pharmaceutical dosage form for mucosal delivery
|
|
US20030153552A1
(en)
|
2002-02-14 |
2003-08-14 |
Mash Deborah C. |
Method of treating chemical dependency in mammals and a composition therefor
|
|
US7700561B2
(en)
|
2002-02-22 |
2010-04-20 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
|
DE10208335A1
(de)
|
2002-02-27 |
2003-09-04 |
Roehm Gmbh |
Arzneiform und Verfahren zu ihrer Herstellung
|
|
US20030199439A1
(en)
|
2002-04-22 |
2003-10-23 |
Simon David Lew |
Compositions of alpha3beta4 receptor antagonists and opioid agonist analgesics
|
|
MXPA04011529A
(es)
|
2002-04-24 |
2005-08-15 |
Cypress Bioscience Inc |
Prevencion y tratamiento de trastornos somaticos funcionales, incluyendo trastornos relacionados con la tension.
|
|
WO2003092676A1
(en)
|
2002-04-29 |
2003-11-13 |
The General Hospital Corporation |
Compositions and methods for preventing abuse of orally administered medications
|
|
AUPS317102A0
(en)
|
2002-06-25 |
2002-07-18 |
Drug Delivery Solutions Pty Ltd |
Transdermal aerosol compositions
|
|
JP2005537244A
(ja)
|
2002-06-28 |
2005-12-08 |
ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド |
療法化合物の粘膜搬送を増進させるための、上皮接合部接着分子の生理機能を調節する組成物および方法
|
|
US20040006043A1
(en)
|
2002-07-02 |
2004-01-08 |
Ramot University Authority For Applied Research & Industrial Development Ltd. |
Methods, pharmaceutical compositions and pharmaceutical kits for enhancing the therapeutic efficiency of cancer chemotherapeutic agents
|
|
US10738268B2
(en)
|
2016-08-21 |
2020-08-11 |
Insectergy, Llc |
Cannabis nanoemulsion methods
|
|
US20050148673A1
(en)
|
2002-07-11 |
2005-07-07 |
Harbut Ronald E. |
Prolonged administration of NMDA antagonist and safener drug to alter neuropathic pain condition
|
|
AU2003246690B2
(en)
|
2002-07-17 |
2010-03-11 |
Cytos Biotechnology Ag |
Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
|
|
NZ537003A
(en)
|
2002-07-18 |
2008-03-28 |
Cytos Biotechnology Ag |
Hapten-carrier conjugates comprising virus like particles and uses thereof
|
|
US7838034B2
(en)
|
2002-07-30 |
2010-11-23 |
Grunenthal Gmbh |
Intravenous pharmaceutical form of administration
|
|
WO2004014429A1
(ja)
|
2002-08-09 |
2004-02-19 |
Mitsubishi Pharma Corporation |
精神疾患発症脆弱性制御剤
|
|
US20030114512A1
(en)
|
2002-09-09 |
2003-06-19 |
Collier Robert J |
Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma
|
|
WO2004025268A2
(en)
|
2002-09-13 |
2004-03-25 |
Carnegie Mellon University |
Optical biosensors and methods of use thereof
|
|
WO2004026290A1
(en)
|
2002-09-19 |
2004-04-01 |
Merck & Co., Inc. |
Method for treating depression and/or anxiety
|
|
US6913768B2
(en)
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
|
DE10244504A1
(de)
|
2002-09-25 |
2004-04-08 |
Capsulution Nanoscience Ag |
Schnellfreisetzende Darreichungsform mit schwerlöslichem Wirkstoff
|
|
NZ538571A
(en)
|
2002-10-11 |
2007-05-31 |
Idea Ag |
Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
|
|
AU2003304211A1
(en)
|
2002-10-30 |
2005-01-04 |
The Regents Of The University Of California |
Direct micro-patterning of lipid bilayers using uv light and selected uses thereof
|
|
DE10250944B9
(de)
|
2002-10-31 |
2004-09-16 |
Cell Center Cologne Gmbh |
Verwendung eines Stifts zur Applikation von Pflege- oder Wirkstoffen in die Nase
|
|
US7670627B2
(en)
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
|
KR20050101537A
(ko)
|
2002-12-24 |
2005-10-24 |
뉴로켐 (인터내셔널) 리미티드 |
베타-아밀로이드 관련 질환의 치료를 위한 치료 제제
|
|
ATE407117T1
(de)
|
2003-01-16 |
2008-09-15 |
Acadia Pharm Inc |
Selektive serotonin 2a/2c inverse rezeptoragonisten als therapeutika für neurodegenerative erkrankungen
|
|
WO2004064753A2
(en)
|
2003-01-23 |
2004-08-05 |
Acadia Pharmaceuticals Inc |
Use of n-desmethylclozapine to treat human neuropsychiatric disease
|
|
US20040186155A1
(en)
|
2003-01-30 |
2004-09-23 |
Dayno Jeffrey Marc |
Combination therapy for the treatment or prevention of migraine
|
|
EP1603548A4
(en)
|
2003-02-05 |
2007-10-10 |
Myriad Genetics Inc |
METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
|
|
US20040214215A1
(en)
|
2003-03-07 |
2004-10-28 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
WO2004082624A2
(en)
|
2003-03-17 |
2004-09-30 |
Neurohealing Pharmaceuticals, Inc. |
Modafinil-based neurorehabilitation of impaired neurological function associated with injury
|
|
CN101675993A
(zh)
|
2003-03-26 |
2010-03-24 |
赛托斯生物技术公司 |
Melan-a肽类似物-病毒样颗粒偶联物
|
|
US8906413B2
(en)
|
2003-05-12 |
2014-12-09 |
Supernus Pharmaceuticals, Inc. |
Drug formulations having reduced abuse potential
|
|
JP4898445B2
(ja)
|
2003-05-29 |
2012-03-14 |
シャイア エルエルシー |
乱用抵抗性アンフェタミン化合物類
|
|
WO2004108130A1
(en)
|
2003-06-03 |
2004-12-16 |
Beth Israel Deaconess Medical Center |
Methods and compounds for the treatment of vascular stenosis
|
|
EP1644004A4
(en)
|
2003-06-20 |
2010-10-06 |
Ronald Aung-Din |
LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS
|
|
JP4174016B2
(ja)
|
2003-07-11 |
2008-10-29 |
株式会社ビーエル |
競合法によるサイロシン類のイムノクロマトグラフィー検出法及びテストキット
|
|
WO2005007628A1
(en)
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
|
DE10334188B4
(de)
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
|
DE10338174A1
(de)
|
2003-08-20 |
2005-03-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
|
|
US20050203011A1
(en)
|
2003-09-19 |
2005-09-15 |
The Regents Of The University Of California |
Mitigating symptoms and behaviors of substance abuse by modulating GDNF or BDNF pathway activity
|
|
US20050070501A1
(en)
|
2003-09-29 |
2005-03-31 |
New York Blood Center, Inc. |
Water dispersible film
|
|
US9408405B2
(en)
|
2003-10-03 |
2016-08-09 |
Veijlen N.V. |
Use of compounds that are able to increase the serum IGF-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced IGF-1 serum level in humans and animals
|
|
WO2005037199A2
(en)
|
2003-10-10 |
2005-04-28 |
Bristol-Myers Squibb Company |
Pyrazole derivatives as cannabinoid receptor modulators
|
|
WO2005039502A2
(en)
|
2003-10-24 |
2005-05-06 |
Azopax Therapeutics Llc |
Macromer-melt formulations
|
|
US20070053954A1
(en)
|
2003-10-24 |
2007-03-08 |
Rowe Stephen C |
Macromer-melt formulations
|
|
JP2005132747A
(ja)
|
2003-10-29 |
2005-05-26 |
Ajinomoto Co Inc |
老齢伴侶動物の老化行動改善剤
|
|
EP1701725B1
(en)
|
2003-12-16 |
2013-07-31 |
Relevare Aust. Pty Ltd |
Compositions comprising flupirtine and an opioid for use in the treatment of neuropathic pain
|
|
US20050260258A1
(en)
|
2003-12-18 |
2005-11-24 |
The Texas A&M University System |
Use of vitelline protein B as a microencapsulating additive
|
|
US20050215521A1
(en)
|
2003-12-22 |
2005-09-29 |
Karim Lalji |
Modafinil combination therapy for improving sleep quality
|
|
EP1699488A2
(en)
|
2003-12-23 |
2006-09-13 |
Pfizer Products Incorporated |
Therapeutic combination for cognition enhancement and psychotic disorders
|
|
GB0400802D0
(en)
|
2004-01-14 |
2004-02-18 |
Daniolabs Ltd |
Compounds for the treatment of disease
|
|
EP1715843A1
(en)
|
2004-01-29 |
2006-11-02 |
Neuromolecular Inc. |
Combination of a nmda receptor antagonist and a mao-inhibitor or a gadph-inhibitor for the treatment of central nervous system-related conditions
|
|
EP1727538A2
(en)
|
2004-02-13 |
2006-12-06 |
Neuromolecular Inc. |
Combination of an nmda receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other cns disorders
|
|
WO2005079756A2
(en)
|
2004-02-13 |
2005-09-01 |
Neuromolecular, Inc. |
Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
|
|
WO2005082277A1
(en)
|
2004-02-18 |
2005-09-09 |
Stanford University |
Drug delivery systems using mesoporous oxide films
|
|
US20050222270A1
(en)
|
2004-02-26 |
2005-10-06 |
Olney John W |
Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis
|
|
FR2867075B1
(fr)
|
2004-03-03 |
2006-07-14 |
Ethypharm Sa |
Procede de preparation de microspheres biodegradables calibrees
|
|
AU2005222640A1
(en)
|
2004-03-12 |
2005-09-29 |
The Mclean Hospital Corporation |
Salvinorin derivatives and uses thereof
|
|
US20060270592A1
(en)
|
2004-03-19 |
2006-11-30 |
Ophthalmic Research Associates, Inc. |
Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
|
|
EP1737473A4
(en)
|
2004-04-19 |
2009-08-26 |
Noven Therapeutics Llc |
COMBINATIONS OF LITHIUM AND USES THEREOF
|
|
WO2005102390A2
(en)
|
2004-04-22 |
2005-11-03 |
Pfizer Japan, Inc. |
Combinations comprising alpha-2-delta ligands and nmda receptor antagonists
|
|
RU2253461C1
(ru)
|
2004-04-30 |
2005-06-10 |
Общество с ограниченной ответственностью "Паркинфарм" |
Фармацевтическая комбинация, оказывающая влияние на функционирование цнс, способ коррекции состояний, связанных с нарушениями функционирования цнс; фармацевтический набор; средство, способствующее проникновению через гематоэнцефалический барьер лекарственных субстанций и метаболитов; фармацевтическое средство для эндоназального применения
|
|
US20050255091A1
(en)
|
2004-05-14 |
2005-11-17 |
Loomis Gary L |
Hydrogels for biomedical applications
|
|
US20050261278A1
(en)
|
2004-05-21 |
2005-11-24 |
Weiner David M |
Selective serotonin receptor inverse agonists as therapeutics for disease
|
|
US20050265955A1
(en)
|
2004-05-28 |
2005-12-01 |
Mallinckrodt Inc. |
Sustained release preparations
|
|
NL1026634C2
(nl)
|
2004-07-12 |
2006-01-16 |
Willem Jacob Van Der Burg |
Psychofarmaceutisch preparaat en werkzame stof daarin.
|
|
US7799802B2
(en)
|
2004-08-03 |
2010-09-21 |
Institstute of Oriental Medical Science Inc. |
Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation
|
|
US20060030625A1
(en)
|
2004-08-06 |
2006-02-09 |
Cheryle Ram Hart |
Dietary neurotransmitter precursors for balanced synthesis of neurotransmitters
|
|
US20060045865A1
(en)
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
|
JP5270161B2
(ja)
|
2004-09-24 |
2013-08-21 |
ベス イスラエル デアコネス メディカル センター |
妊娠合併症を診断および処置する方法
|
|
WO2006047032A2
(en)
|
2004-09-27 |
2006-05-04 |
Organix, Inc. |
Indole compounds useful as serotonin selective agents
|
|
WO2006042249A2
(en)
|
2004-10-08 |
2006-04-20 |
Neuromolecular Pharmaceuticals, Inc. |
Methods and compositions for treating migraine pain
|
|
EP2417986A1
(en)
|
2004-11-22 |
2012-02-15 |
Anadis Ltd. |
Bioactive compositions
|
|
FR2878161B1
(fr)
|
2004-11-23 |
2008-10-31 |
Flamel Technologies Sa |
Forme medicamenteuse orale, solide et concue pour eviter le mesusage
|
|
FR2878158B1
(fr)
|
2004-11-24 |
2009-01-16 |
Flamel Technologies Sa |
Forme pharmaceutique orale, microparticulaire solide concue pour eviter le mesusage
|
|
US20060110327A1
(en)
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US7294649B2
(en)
|
2004-12-17 |
2007-11-13 |
Roche Diagnostics Operatins, Inc. |
Methamphetamine derivatives and conjugates for immunoassay
|
|
JP2008524332A
(ja)
|
2004-12-20 |
2008-07-10 |
コレジウム ファーマシューティカル， インク． |
睡眠傷害のための医薬組成物
|
|
EP1844189B1
(en)
|
2005-01-10 |
2020-10-28 |
Smiths Detection Inc. |
Method for preparing a sampling swab
|
|
DE102005004343A1
(de)
|
2005-01-25 |
2006-08-10 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
Behandlung von Phantomphänomenen
|
|
FR2881652B1
(fr)
|
2005-02-08 |
2007-05-25 |
Flamel Technologies Sa |
Forme pharmaceutique orale microparticulaire anti-mesuage
|
|
US8318210B2
(en)
|
2005-02-28 |
2012-11-27 |
Neos Therapeutics, Lp |
Compositions and methods of making sustained release liquid formulations
|
|
MX2007011250A
(es)
|
2005-03-21 |
2007-11-14 |
Ivax Pharmaceuticals Sro |
Inhibidor de la cristalizacion y su uso en capsulas de gelatina.
|
|
CN101146828B
(zh)
|
2005-03-23 |
2011-07-27 |
Bpsi控股有限公司 |
聚结的淀粉组合物
|
|
US20090232898A1
(en)
|
2005-03-28 |
2009-09-17 |
Anders Pettersson |
Pharmaceutical Compositions Useful in the Treatment of Migraine
|
|
US20060229293A1
(en)
|
2005-04-06 |
2006-10-12 |
Addiction Research Institute, Inc. |
Compositions for the treatment of hepatitis C and methods for using compositions for the treatment of hepatitis C
|
|
EP1865980A4
(en)
|
2005-04-08 |
2009-11-11 |
Shire Llc |
ABUSEFUL AMPHETAMINE PRODRUGS
|
|
US20090156581A1
(en)
|
2005-04-15 |
2009-06-18 |
Board Of Trustrees Of Michigan State University |
Aminergic pharmaceutical compositions and methods
|
|
CN101203250B
(zh)
|
2005-04-15 |
2013-03-20 |
界面生物公司 |
经由非共价相互作用递送生物活性剂的方法、组合物及成形物件
|
|
GT200600159A
(es)
|
2005-04-22 |
2007-03-14 |
|
Derivados benzodioxano y benzodioxolano y usos de los mismos
|
|
CA2607576C
(en)
|
2005-05-06 |
2013-07-09 |
Smiths Detection Inc. |
Improved chemical identification of peroxide-based explosives
|
|
US8859585B2
(en)
|
2005-05-25 |
2014-10-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Scopolamine for the treatment of depression and anxiety
|
|
GB0511060D0
(en)
|
2005-05-31 |
2005-07-06 |
Novartis Ag |
Organic compounds
|
|
JP5284779B2
(ja)
|
2005-06-07 |
2013-09-11 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド |
コンジュゲート化された向精神薬の新規な塩およびその調製方法
|
|
CA2612309C
(en)
|
2005-06-16 |
2014-12-16 |
Mohammed Saeed |
Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent
|
|
US7645802B2
(en)
|
2005-06-27 |
2010-01-12 |
Biovail Laboratories International Srl. |
Bupropion hydrobromide and therapeutic applications
|
|
EP1906937B1
(en)
|
2005-07-22 |
2016-10-19 |
Rubicon Research Pvt Ltd. |
Novel dispersible tablet composition
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
US20070092586A1
(en)
|
2005-10-26 |
2007-04-26 |
Alamo Pharmaceuticals |
Compositions and methods for the administration psychotropic drugs which modulate body weight
|
|
DE102005055866A1
(de)
|
2005-11-23 |
2007-05-24 |
Hte Ag The High Throughput Experimentation Company |
Verfahren zur Herstellung von Aryl-Aryl gekoppelter Verbindungen
|
|
RU2433817C2
(ru)
|
2006-01-21 |
2011-11-20 |
Эбботт Гмбх Унд Ко.Кг |
Лекарственная форма и способ для доставки вызывающих зависимость лекарственных веществ
|
|
CN101336116B
(zh)
|
2006-02-02 |
2013-01-02 |
医学技术设备公司 |
一种包含溶胶-凝胶组合物的生物活性物质输送系统
|
|
US20070203216A1
(en)
|
2006-02-14 |
2007-08-30 |
Bjarke Ebert |
Method of treating inflammatory diseases
|
|
US20070190130A1
(en)
|
2006-02-16 |
2007-08-16 |
Mark William A |
Protein hydrolysate excipients
|
|
US20080075789A1
(en)
|
2006-02-28 |
2008-03-27 |
The Regents Of The University Of California |
Genes differentially expressed in bipolar disorder and/or schizophrenia
|
|
EP1998788A4
(en)
|
2006-03-01 |
2011-08-03 |
Ruey J Yu |
COMPOSITIONS AND METHODS FOR THE TOPIC TREATMENT OF DERMATOLOGICAL DISORDERS RESPONSIBLE FOR TAR
|
|
FR2898271B1
(fr)
|
2006-03-09 |
2009-01-16 |
Pierre Fabre Medicament Sa |
Nouvelle utilisation d'agents antihistaminiques pour le traitement preventif ou procede de syndromes inflammatoires, en particulier ceux declenches par les toga virus.
|
|
JP2009530385A
(ja)
|
2006-03-22 |
2009-08-27 |
マウント シナイ スクール オブ メディシン |
うつ病の治療のためのケタミンの鼻内投与
|
|
WO2006079999A2
(en)
|
2006-04-09 |
2006-08-03 |
Barth Frederik H |
Induction of a novel state of mind with a 5-ht2a agonist and a nmda antagonist
|
|
US8445016B2
(en)
|
2006-04-14 |
2013-05-21 |
Interface Biologics, Inc. |
Grafted polymers and uses thereof
|
|
GB0608647D0
(en)
|
2006-05-02 |
2006-06-14 |
Haritou Susan J A |
Methods of diagnosis and treatment
|
|
US8846100B2
(en)
|
2006-05-12 |
2014-09-30 |
Shire Llc |
Controlled dose drug delivery system
|
|
ES2529455T3
(es)
|
2006-05-12 |
2015-02-20 |
Shire Llc |
Sistema de administración de fármacos por dosis controladas
|
|
HRP20120479T1
(hr)
|
2006-06-28 |
2012-07-31 |
Chelsea@Therapeutics@Inc |
Farmaceutski sastavi sa droksidopom
|
|
EP2040758A4
(en)
|
2006-06-30 |
2014-09-17 |
Interface Biologics Inc |
BIORESPONSIVE POLYMERS
|
|
WO2008010223A2
(en)
|
2006-07-17 |
2008-01-24 |
Ramot At Tel Aviv University Ltd. |
Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use in treating pain and other cns disorders
|
|
WO2008009125A1
(en)
|
2006-07-20 |
2008-01-24 |
Cascade Therapeutics Inc. |
Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands
|
|
US20080026189A1
(en)
|
2006-07-27 |
2008-01-31 |
Chun-Wei Lin |
Thin key structure for generating dazzling light
|
|
JP5243428B2
(ja)
|
2006-08-23 |
2013-07-24 |
ザ ユニヴァーシティ オブ モンタナ |
神経細胞の損傷を減少させるための薬学的組成物
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
WO2008026046A1
(en)
|
2006-08-30 |
2008-03-06 |
Pfizer Products Inc. |
Morpholine d3 dopamine antagonists
|
|
JP2010502623A
(ja)
|
2006-08-31 |
2010-01-28 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Ｎｏｇｏレセプターポリペプチドの末梢投与に関する方法
|
|
EP2066355A2
(en)
|
2006-09-19 |
2009-06-10 |
Braincells, Inc. |
Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
|
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
|
EP2083825A4
(en)
|
2006-09-26 |
2009-11-04 |
Addiction Res Inst Inc |
HEPATITIS C TREATMENT COMPOSITIONS AND METHODS OF USING HEPATITIS C TREATMENT COMPOSITIONS
|
|
WO2008038291A1
(en)
|
2006-09-27 |
2008-04-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Combination of liposomal anti-cancer drugs and lysosome/endosome ph increasing agents for therapy
|
|
JP2010508279A
(ja)
|
2006-10-27 |
2010-03-18 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
破壊的行動障害の処置法
|
|
EP2420235A1
(en)
|
2006-10-27 |
2012-02-22 |
Medivation Neurology, Inc. |
Methods and combination therapies for treating alzheimer's disease
|
|
JP2010508354A
(ja)
|
2006-10-31 |
2010-03-18 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
広汎性発達障害の処置
|
|
US7718649B1
(en)
|
2006-11-10 |
2010-05-18 |
Pisgah Labs, Inc. |
Physical states of a pharmaceutical drug substance
|
|
US20080293695A1
(en)
|
2007-05-22 |
2008-11-27 |
David William Bristol |
Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
|
|
US8653106B2
(en)
|
2010-07-30 |
2014-02-18 |
Pisgah Laboratories, Inc. |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
|
|
US7776917B2
(en)
|
2006-12-11 |
2010-08-17 |
Mickle Travis C |
Non-standard amino acid conjugates of amphetamine and processes for making and using the same
|
|
ES2302650B1
(es)
|
2007-01-11 |
2009-02-16 |
Tedec-Meiji Farma, S.A. |
Composicion de rapida desintegracion en la cavidad bucal.
|
|
WO2008095086A2
(en)
|
2007-01-31 |
2008-08-07 |
University Of Virginia Patent Foundation |
Topiramate plus naltrexone for the treatment of addictive disorders
|
|
EP2109465B1
(en)
|
2007-02-08 |
2012-04-11 |
Kempharm, Inc. |
Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same
|
|
AU2008226541B2
(en)
|
2007-03-09 |
2013-05-09 |
Chelsea Therapeutics, Inc. |
Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia
|
|
US20080227830A1
(en)
|
2007-03-12 |
2008-09-18 |
Chelsea Therapeutics, Inc. |
Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
|
|
WO2008115797A1
(en)
|
2007-03-16 |
2008-09-25 |
Pavo, Inc. |
Therapeutic compositions and methods
|
|
DE102007014286A1
(de)
|
2007-03-19 |
2008-09-25 |
Universität Tübingen |
Fluorsubstituierte Amphetamine und Amphetaminderivate und deren Verwendung
|
|
CA2682432C
(en)
|
2007-03-30 |
2017-06-06 |
Duke University |
Device and method for delivery of a medicament
|
|
AT505086B1
(de)
|
2007-04-02 |
2009-06-15 |
Planta Naturstoffe Vertriebsge |
Pharmazeutisches mittel gegen juckreiz und juckreizbedingten schmerz
|
|
WO2008122990A1
(en)
|
2007-04-04 |
2008-10-16 |
Almet Corporation Limited |
Compacting upflow extractor and method of using it
|
|
WO2008128193A1
(en)
|
2007-04-12 |
2008-10-23 |
Rutgers, The State University Of New Jersey |
Biodegradable polyanhydrides with natural bioactive molecules
|
|
KR20090018964A
(ko)
|
2007-04-18 |
2009-02-24 |
테바 파마슈티컬 인더스트리즈 리미티드 |
Ｈｍｇ-ｃｏａ 환원 효소 억제제의 중간체의 제조 방법
|
|
EP2139848A1
(en)
|
2007-04-26 |
2010-01-06 |
Auspex Pharmaceuticals, Inc. |
Deuterium labelled ketamine
|
|
US9421266B2
(en)
|
2007-05-22 |
2016-08-23 |
Pisgah Laboratories, Inc. |
Safety of pseudoephedrine drug products
|
|
US10183001B1
(en)
|
2007-05-22 |
2019-01-22 |
Pisgah Laboratories, Inc. |
Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
|
|
EP2182957A4
(en)
|
2007-07-31 |
2012-07-18 |
Limerick Biopharma Inc |
PHOSPHORYLATED PYRONANALOGES AND CORRESPONDING METHODS
|
|
ES2653852T3
(es)
|
2007-08-03 |
2018-02-09 |
Richter Gedeon Nyrt. |
Composiciones farmacéuticas que contienen ligandos del receptor de dopamina y procedimientos de tratamiento usando ligandos del receptor de dopamina
|
|
FR2919861A1
(fr)
|
2007-08-06 |
2009-02-13 |
Sanofi Aventis Sa |
Le solvate d'isopranol de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
|
|
AU2016208412A1
(en)
|
2007-08-06 |
2016-08-18 |
Biotie Therapies, Inc. |
Methods for treating dependence
|
|
RU2491067C2
(ru)
|
2007-08-06 |
2013-08-27 |
Байотай Терапис, Инк |
Способы лечения зависимости
|
|
EP2183227B1
(en)
|
2007-08-07 |
2014-09-24 |
Prosarix Limited |
1,2,4-triazole derivatives as serotonergic modulators
|
|
US8067028B2
(en)
|
2007-08-13 |
2011-11-29 |
Confluent Surgical Inc. |
Drug delivery device
|
|
US8318813B2
(en)
|
2007-09-13 |
2012-11-27 |
Lcs Group, Llc |
Method of treating binge eating disorder
|
|
JP5599712B2
(ja)
|
2007-10-05 |
2014-10-01 |
インターフェース バイオロジクス，インコーポレーテッド |
オリゴフッ素化架橋ポリマーおよびそれの使用
|
|
US20110053859A1
(en)
|
2007-10-10 |
2011-03-03 |
The U. S. Government Respresented by the Department of Veterans Affairs |
Methods to reduce the effects of sleep deprivation
|
|
WO2009055001A2
(en)
|
2007-10-23 |
2009-04-30 |
Fred Hutchinson Cancer Research Center |
Methods of treating aging and methods of screening candidate agents therefor
|
|
WO2009061436A1
(en)
|
2007-11-06 |
2009-05-14 |
University Of Florida Research Foundation |
Compound for activating 5-ht2c receptors in combination with an amphetamine compound
|
|
DE102007063210A1
(de)
|
2007-12-20 |
2009-06-25 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
Arzneimittel zur Behandlung von Phantomphänomenen
|
|
WO2009079765A1
(en)
|
2007-12-21 |
2009-07-02 |
Cascade Therapeutics Inc. |
Compounds with activity at the 5-ht2c receptor
|
|
WO2009089234A2
(en)
|
2008-01-07 |
2009-07-16 |
Auspex Pharmaceuticals |
Substituted dibenzhydrylpiperazines
|
|
EP2240022B1
(en)
|
2008-01-09 |
2016-12-28 |
Charleston Laboratories, Inc. |
Bilayered tablets comprising oxycodone and promethazine
|
|
WO2009091605A2
(en)
|
2008-01-17 |
2009-07-23 |
Health Innovations, Llc |
Taste titration therapies
|
|
US8329663B2
(en)
|
2008-01-31 |
2012-12-11 |
Paul Griffin |
Compositions and methods for the treatment of chronic infections
|
|
WO2009097596A1
(en)
|
2008-01-31 |
2009-08-06 |
Paul Griffin |
Compositions and methods for the treatment of chronic infections
|
|
LT2237799T
(lt)
|
2008-02-01 |
2019-07-25 |
Ascendis Pharma A/S |
Provaistas, apimantis besiskaidantį linkerį
|
|
WO2009109428A2
(en)
|
2008-02-01 |
2009-09-11 |
Alpha-O Peptides Ag |
Self-assembling peptide nanoparticles useful as vaccines
|
|
US20090198145A1
(en)
|
2008-02-06 |
2009-08-06 |
Chow Harrison |
Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep
|
|
US20090318527A1
(en)
|
2008-02-11 |
2009-12-24 |
Howard Sard |
Indole compounds and methods of use thereof
|
|
US8859579B2
(en)
|
2008-03-21 |
2014-10-14 |
Richard Andrew Sewell |
Compostions and methods for preventing and/or treating disorders associated with cephalic pain
|
|
US20110275872A1
(en)
|
2008-03-26 |
2011-11-10 |
Paul Hanselmann |
Process for the synthesis of ethynylcyclopropane
|
|
US20170276676A1
(en)
|
2008-03-27 |
2017-09-28 |
Gus J. Slotman |
System for assessing drug efficacy and response of a patient to therapy
|
|
WO2009118763A1
(en)
|
2008-03-28 |
2009-10-01 |
Panacea Biotec Limited |
Multilayered pharmaceutical compositions and processes thereof
|
|
EP2106799A1
(en)
|
2008-03-31 |
2009-10-07 |
OWEN Holding LTD |
Use of a biologically active blood serum for the treatment of a disorder characterized in a reduced function of a GABA receptor
|
|
US20090252786A1
(en)
|
2008-03-31 |
2009-10-08 |
Christoph Hanz |
Use of a Biologically Active Blood Serum for the Treatment of a Disorder Characterized in a Reduced Function of a GABA Receptor
|
|
FR2930147B1
(fr)
|
2008-04-18 |
2013-02-08 |
Flamel Tech Sa |
Forme orale solide dotee d'un double profil de liberation
|
|
US20110118189A1
(en)
|
2008-04-28 |
2011-05-19 |
Farr Stephen J |
Novel formulations for treatment of migraine
|
|
WO2009149252A1
(en)
|
2008-06-04 |
2009-12-10 |
Cornell University |
Vaccines for prevention and treatment of addiction
|
|
US10388179B2
(en)
|
2008-06-18 |
2019-08-20 |
Accenture Global Solutions Limited |
Analytics platform
|
|
JP5620907B2
(ja)
|
2008-06-19 |
2014-11-05 |
エルテーエスローマン テラピー−ジステーメ アーゲー |
カチオン性活性剤の経皮送達のための組成物
|
|
EP2313037A1
(en)
|
2008-06-30 |
2011-04-27 |
Oron Zachar |
Dermal application of vasoconstrictors
|
|
US8617607B2
(en)
|
2008-07-10 |
2013-12-31 |
Tyrx, Inc. |
Sustained release formulations of psychoactive drugs
|
|
US9642819B2
(en)
|
2008-07-10 |
2017-05-09 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical |
Low dosage serotonin 5-HT2A receptor agonist to suppress inflammation
|
|
MX2011001384A
(es)
|
2008-08-06 |
2011-09-27 |
Gosforth Ct Holdings Pty Ltd |
Composiciones y metodos para tratar trastornos psiquiatricos.
|
|
FR2935611B1
(fr)
|
2008-09-10 |
2010-10-15 |
Commissariat Energie Atomique |
Utilisation d'agents anti-connexines pour moduler l'effet therapeutique de molecules psychotropes
|
|
FR2936710B1
(fr)
|
2008-10-07 |
2011-01-07 |
Ceva Sante Animale |
Composition veterinaire antiprolactinique destinee aux ruminants
|
|
MX353752B
(es)
|
2009-01-20 |
2018-01-26 |
Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct |
Los ácidos sórbico y benzoico y sus derivados aumentan la actividad de un neurofármaco.
|
|
UA105657C2
(uk)
|
2009-02-27 |
2014-06-10 |
Хелсінн Терапьютікс (Ю.Ес.), Інк. |
Поліпшені способи лікування мігрені на основі анамореліну
|
|
WO2010124089A2
(en)
|
2009-04-22 |
2010-10-28 |
Synosia Therapeutics, Inc. |
Methods for treating dependence
|
|
WO2010123577A2
(en)
|
2009-04-24 |
2010-10-28 |
Galenea Corp. |
Compositions and methods for evaluating cognitive deficits
|
|
US20100303903A1
(en)
|
2009-05-26 |
2010-12-02 |
Shire Llc |
Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
|
|
GB201111485D0
(en)
|
2011-07-05 |
2011-08-17 |
Biocopea Ltd |
Drug composition and its use in therapy
|
|
US20110306596A1
(en)
|
2009-07-27 |
2011-12-15 |
Auspex Pharmaceuticals, Inc. |
Benzazepine inhibitors of gamma-secretase
|
|
US20120302590A1
(en)
|
2009-08-13 |
2012-11-29 |
The General Hospital Corporation |
Methods and compositions to prevent addiction
|
|
US20110038915A1
(en)
|
2009-08-14 |
2011-02-17 |
Eduardo Jose Gonzalez |
Chewing Gum Formula for Enhancing Psycho-Spirituality
|
|
US20120171239A1
(en)
|
2009-09-03 |
2012-07-05 |
Mizel Steven B |
Immunogenic Conjugates for Producing Immune Responses to Drugs of Abuse and Methods of Use
|
|
FR2954167A1
(fr)
|
2009-09-04 |
2011-06-24 |
Centre Nat Rech Scient |
Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique
|
|
FR2951378B1
(fr)
|
2009-10-16 |
2012-06-01 |
Flamel Tech Sa |
Forme pharmaceutique orale solide anti-mesusage et dotee d'un profil specifique de liberation modifiee
|
|
US20120282299A1
(en)
|
2009-10-16 |
2012-11-08 |
Soazig Claude Marie Delamarre |
Coatings comprising bis-(alpha-amino-diol-diester) containing polyesteramide
|
|
WO2011048494A2
(en)
|
2009-10-19 |
2011-04-28 |
Intec Pharma Ltd. |
Novel gastroretentive dosage forms of poorly soluble drugs
|
|
EP2513225A4
(en)
|
2009-12-18 |
2015-08-12 |
Interface Biologics Inc |
LOCAL ACTIVE INGREDIENT RELIEF FROM SELF-ORDINATED COATINGS
|
|
EP2531200B1
(en)
|
2010-02-06 |
2017-07-12 |
Grünenthal GmbH |
Crystallization method and bioavailability
|
|
US20110217289A1
(en)
|
2010-03-05 |
2011-09-08 |
Basf Se |
Melt-Coated Dosage Forms
|
|
CA2829180C
(en)
|
2010-03-05 |
2019-01-15 |
Newagriculture, Inc. |
Leaf protein-lipid-soluble material complexes
|
|
WO2011116189A1
(en)
|
2010-03-17 |
2011-09-22 |
Cornell University |
Disrupted adenovirus-based vaccine against drugs of abuse
|
|
WO2011138142A1
(en)
|
2010-05-07 |
2011-11-10 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Compositions and use of sulfasalazine
|
|
KR20130070608A
(ko)
|
2010-05-10 |
2013-06-27 |
세게티스, 인코포레이티드. |
미립자 고체에 대한 분산제 및 슬립제로서의 알킬 케탈 에스터 및 그의 제조방법, 및 용도
|
|
US8765737B1
(en)
|
2010-05-11 |
2014-07-01 |
Demerx, Inc. |
Methods and compositions for preparing and purifying noribogaine
|
|
US8362007B1
(en)
|
2010-05-11 |
2013-01-29 |
Demerx, Inc. |
Substituted noribogaine
|
|
US20120108510A1
(en)
|
2010-05-20 |
2012-05-03 |
Emory University |
Methods of improving behavioral therapies
|
|
JP2012020991A
(ja)
|
2010-06-16 |
2012-02-02 |
Takasago Internatl Corp |
経皮吸収促進剤、及びこれを含有する皮膚外用製剤
|
|
US8802832B2
(en)
|
2010-06-22 |
2014-08-12 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
|
CA2806232A1
(en)
|
2010-07-23 |
2012-01-26 |
Demerx, Inc. |
Noribogaine compositions
|
|
US20120039999A1
(en)
|
2010-08-11 |
2012-02-16 |
Ashish Chatterji |
Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
|
|
EP3333185A1
(en)
|
2010-08-20 |
2018-06-13 |
Heptares Therapeutics Limited |
Mutant gpcrs
|
|
KR20130100290A
(ko)
|
2010-08-30 |
2013-09-10 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
협착성 병변을 위한 전단 제어 방출 및 혈전 용해 치료법
|
|
WO2012031125A2
(en)
|
2010-09-01 |
2012-03-08 |
The General Hospital Corporation |
Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine
|
|
US20120129834A1
(en)
|
2010-09-17 |
2012-05-24 |
Buck Institute For Research On Aging |
Serotonin receptor antagonists for use in the treatment of huntington's disease
|
|
WO2012039660A1
(en)
|
2010-09-20 |
2012-03-29 |
A. Carlsson Research Ab |
Phenylpiperidine compounds for the treatment of neurological and psychiatric disorders
|
|
CN103249407B
(zh)
|
2010-10-07 |
2017-05-17 |
鹰制药私人有限公司 |
用于治疗抑郁症和其他非感染性疾病的联合疗法
|
|
WO2012054815A1
(en)
|
2010-10-22 |
2012-04-26 |
Duke University |
Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies
|
|
US20130230587A1
(en)
|
2010-11-10 |
2013-09-05 |
Rubicon Research Private Limited |
Sustained release compositions
|
|
WO2012066537A2
(en)
|
2010-11-15 |
2012-05-24 |
Neuroderm Ltd |
Compositions for transdermal delivery of active agents
|
|
CN103354902B
(zh)
|
2010-12-06 |
2016-03-02 |
特拉维夫大学拉玛特有限公司 |
药物检测方法和试剂盒
|
|
IL298116A
(en)
|
2010-12-22 |
2023-01-01 |
Syqe Medical Ltd |
Method and system for drug delivery
|
|
EP2481740B1
(en)
|
2011-01-26 |
2015-11-04 |
DemeRx, Inc. |
Methods and compositions for preparing noribogaine from voacangine
|
|
FR2971423B1
(fr)
|
2011-02-15 |
2014-01-10 |
Ceva Sante Animale |
Composition veterinaire antiprolactinique destinee aux ruminants
|
|
US8742096B2
(en)
|
2011-03-28 |
2014-06-03 |
Demerx, Inc. |
Methods and compositions for preparing noribogaine from voacangine
|
|
US20140017803A1
(en)
|
2011-03-28 |
2014-01-16 |
Flir Systems, Inc. |
Detection of analytes including drugs
|
|
TWI636784B
(zh)
|
2011-04-05 |
2018-10-01 |
大塚製藥股份有限公司 |
含7-〔4-(4-苯並〔b〕噻吩-4-基-哌-1-基)丁氧基〕-1H-喹啉-2-酮之醫藥組成物與套組，以及彼之用途
|
|
US20120282255A1
(en)
|
2011-04-07 |
2012-11-08 |
Greg Plucinski |
Methods and compositions for the treatment of alcoholism and alcohol dependence
|
|
KR20120128440A
(ko)
|
2011-05-17 |
2012-11-27 |
삼성전자주식회사 |
표적 물질 검출용 키트 및 이를 이용한 표적 물질 검출 방법
|
|
US9089563B2
(en)
|
2011-05-19 |
2015-07-28 |
Gilrose Pharmaceuticals, Llc |
Method of treating apraxia of speech in children
|
|
US20140163070A1
(en)
|
2012-05-17 |
2014-06-12 |
Bruce Roseman |
Treatment for cerebral palsy impaired speech in children
|
|
KR20140042868A
(ko)
|
2011-06-23 |
2014-04-07 |
맵 파마슈티컬스, 인코포레이티드 |
신규한 플루오로에르골린 유사체
|
|
US9040520B2
(en)
|
2011-09-15 |
2015-05-26 |
Demerx, Inc. |
Noribogaine salt ansolvates
|
|
WO2013061161A2
(en)
|
2011-10-28 |
2013-05-02 |
Green Bcn Consulting Services Sl |
New combination therapies for treating neurological disorders
|
|
RU2636350C2
(ru)
|
2011-11-07 |
2017-11-22 |
Новартис Аг |
МОЛЕКУЛА, СОДЕРЖАЩАЯ SPR0096 и SPR2021
|
|
FR2983409B1
(fr)
|
2011-12-06 |
2013-12-27 |
Ethypharm Sa |
Comprime susceptible de lutter contre le detournement par voie injectable
|
|
WO2013085850A2
(en)
|
2011-12-08 |
2013-06-13 |
Demerx, Inc. |
Stereoselective total synthesis of noribogaine
|
|
CA2855990A1
(en)
|
2011-12-09 |
2013-06-13 |
Demerx, Inc. |
Sulfate esters of noribogaine
|
|
WO2013085922A1
(en)
|
2011-12-09 |
2013-06-13 |
Demerx, Inc. |
Phosphate esters of noribogaine
|
|
EP2607352A1
(en)
|
2011-12-22 |
2013-06-26 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pipecolate-diketoamides for treatment of psychiatric disorders
|
|
EP2610245A1
(en)
|
2011-12-28 |
2013-07-03 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pipecolate-sulfonamides for treatment of psychiatric disorders
|
|
CA2858105A1
(en)
|
2012-01-25 |
2013-08-01 |
Demerx, Inc. |
Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
|
|
WO2013112673A1
(en)
|
2012-01-25 |
2013-08-01 |
Demerx, Inc. |
Synthetic voacangine
|
|
WO2013112163A1
(en)
|
2012-01-25 |
2013-08-01 |
Demerx, Inc. |
Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
|
|
EP2649989B1
(en)
|
2012-04-13 |
2017-10-18 |
King Saud University |
Method for preparing a solid dispersion, solid dispersion obtained thereby and use thereof
|
|
US20130295170A1
(en)
|
2012-05-03 |
2013-11-07 |
Kydes Pharmaceuticals Llc |
Compositions for control of drug abuse
|
|
US20130295016A1
(en)
|
2012-05-07 |
2013-11-07 |
David J. Gerber |
Signatures of electroencephalographic oscillations
|
|
BR112014028094B1
(pt)
|
2012-05-09 |
2022-03-03 |
Cantex Pharmaceuticals, Inc |
Uso de um heparinoide interagindo com fator de plaqueta 4
|
|
US20150196533A1
(en)
|
2012-07-02 |
2015-07-16 |
The General Hospital Corporation |
Method for concurrent treatment of pain and depression
|
|
US8784835B2
(en)
|
2012-07-02 |
2014-07-22 |
Trent Austin |
Method for producing muscimol and/or reducing ibotenic acid from amanita tissue
|
|
EP2690102A1
(en)
|
2012-07-24 |
2014-01-29 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Bicyclic aza-amides for treatment of psychiatric disorders
|
|
EA035868B1
(ru)
|
2012-08-17 |
2020-08-24 |
Смартек Интернэшнл Эл-Эл-Си |
Приготовление высушенных липосом для применения в системах выпуска в прессованном виде
|
|
CN104736176B
(zh)
|
2012-08-24 |
2017-10-13 |
英特格拉斯疗法有限公司 |
用于增强治疗剂透皮递送的化学组合物和方法
|
|
US20140066881A1
(en)
|
2012-08-31 |
2014-03-06 |
Zoll Medical Corporation |
Cardiac resuscitation methods and kits
|
|
US20140100282A1
(en)
|
2012-10-10 |
2014-04-10 |
Patrick S L Wong |
Intranasal administration of pharmaceutical agents for treatment of neurological diseases
|
|
US20150231300A1
(en)
|
2012-10-28 |
2015-08-20 |
Peritech Pharma Ltd. |
Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
|
|
CN105189492A
(zh)
|
2012-11-19 |
2015-12-23 |
萨克·W·金 |
麦角灵衍生物作为多巴胺受体调节剂
|
|
US9737562B2
(en)
|
2012-12-11 |
2017-08-22 |
The Mclean Hospital Corporation |
Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disorders
|
|
EP2934541A4
(en)
|
2012-12-20 |
2016-08-03 |
Demerx Inc |
SUBSTITUTED NORIBOGAIN
|
|
US10555916B2
(en)
|
2013-01-25 |
2020-02-11 |
Case Western Reserve University |
NMDAR antagonist for the treatment of pervasive development disorders
|
|
US20140294923A1
(en)
|
2013-02-20 |
2014-10-02 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of migraine headache
|
|
WO2014140925A2
(en)
|
2013-03-10 |
2014-09-18 |
Peritech Pharma Ltd. |
Topical compositions and methods of treatment of topical disorders
|
|
WO2014153099A2
(en)
|
2013-03-14 |
2014-09-25 |
Pulmonary Analytics |
Method for using exhaled breath to determine the presence of drug
|
|
CA2942638C
(en)
|
2013-03-15 |
2026-03-10 |
Demerx, Inc. |
Method for noribogaine treatment of addiction in patients on methadone
|
|
KR20210113429A
(ko)
|
2013-03-15 |
2021-09-15 |
멜리어 파마슈티칼스 투, 엘엘씨. |
시드노카브 또는 이의 약학적으로 허용되는 염을 포함하는 약학적 조성물 및 수면 장애를 치료하는 방법
|
|
WO2014142938A1
(en)
|
2013-03-15 |
2014-09-18 |
Aihol Corporation |
Pharmaceutical formulation containing glycosaminoglycan
|
|
US20160030408A1
(en)
|
2013-03-15 |
2016-02-04 |
Bhl Patent Holdings Llc |
Materials and methods for treating neuropathies and related disorders including those involving a keystone nerve
|
|
US20160077091A1
(en)
|
2013-04-26 |
2016-03-17 |
Express Diagnostics International, Inc. |
Portable testing system for detecting selected drugs or compounds in noncontrolled environments
|
|
WO2014186623A2
(en)
|
2013-05-17 |
2014-11-20 |
Biomed Valley Discoveries |
Methods and compositions for the treatment of a chagas disease
|
|
MX2015016254A
(es)
|
2013-05-29 |
2016-04-20 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
|
|
CA2817728A1
(en)
|
2013-05-31 |
2014-11-30 |
Pharmascience Inc. |
Abuse deterrent immediate release formulation
|
|
WO2014195872A1
(en)
|
2013-06-04 |
2014-12-11 |
Vyome Biosciences Pvt. Ltd. |
Coated particles and compositions comprising same
|
|
US20140364367A1
(en)
|
2013-06-08 |
2014-12-11 |
Sedogen, Llc |
Methods of treating prader willi syndrome and conditions associated with low basal metabolic rate or hyperphagia using a katp channel opener
|
|
EP2818177A1
(en)
|
2013-06-24 |
2014-12-31 |
Celica, D.O.O. |
Mechanism and drug targets for reducing cell edema (neuroprotection) and cytoplasmic excitability in astrocytes in normal and pathological states
|
|
US20150011644A1
(en)
|
2013-07-03 |
2015-01-08 |
Acura Pharmaceuticals, Inc. |
Methods and Compositions for Deterring Abuse
|
|
AU2014287418A1
(en)
|
2013-07-08 |
2016-01-28 |
Auspex Pharmaceuticals, Inc. |
Dihydroxyphenyl neurotransmitter compounds, compositions and methods
|
|
AU2014289187B2
(en)
|
2013-07-12 |
2019-07-11 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
|
|
US9770514B2
(en)
|
2013-09-03 |
2017-09-26 |
ExxPharma Therapeutics LLC |
Tamper-resistant pharmaceutical dosage forms
|
|
US10098893B2
(en)
|
2013-10-03 |
2018-10-16 |
Northwestern University |
Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to patients having the minor allele of the single nucleotide polymorphism rs2237457
|
|
US9474481B2
(en)
|
2013-10-22 |
2016-10-25 |
Mindstrong, LLC |
Method and system for assessment of cognitive function based on electronic device usage
|
|
US9420970B2
(en)
|
2013-10-22 |
2016-08-23 |
Mindstrong, LLC |
Method and system for assessment of cognitive function based on mobile device usage
|
|
US20160256392A1
(en)
|
2013-10-31 |
2016-09-08 |
Cima Labs Inc. |
Abuse-deterrent dosage forms
|
|
WO2015065547A1
(en)
|
2013-10-31 |
2015-05-07 |
Cima Labs Inc. |
Immediate release abuse-deterrent granulated dosage forms
|
|
TW201605856A
(zh)
|
2013-11-01 |
2016-02-16 |
艾尼納製藥公司 |
５－ＨＴｃ受體促效劑
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
CN103535561A
(zh)
|
2013-11-05 |
2014-01-29 |
杨剑 |
饲养大猪用的牧草饲料
|
|
CN103549133A
(zh)
|
2013-11-05 |
2014-02-05 |
杨剑 |
有机猪牧草饲料
|
|
CN103751943B
(zh)
|
2014-01-13 |
2020-10-13 |
湖北及安盾消防科技有限公司 |
一种含有含氮类有机化合物的灭火组合物
|
|
AU2014379612A1
(en)
|
2014-01-24 |
2016-08-11 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
|
CN103773056B
(zh)
|
2014-01-24 |
2015-11-18 |
山东大学 |
高脆性透明类岩石材料试件制备方法
|
|
AU2015225442A1
(en)
|
2014-03-03 |
2016-10-20 |
Demerx, Inc. |
Therapeutic uses of ibogaine and related compounds
|
|
US20150258114A1
(en)
|
2014-03-13 |
2015-09-17 |
Demerx, Inc. |
Methods for acute and long-term treatment of substance abuse using ibogaine
|
|
EP3151906B1
(en)
|
2014-06-03 |
2019-12-11 |
Pop Test Abuse Deterrent Technology LLC |
Drug device configured for wireless communication
|
|
EP3174893B1
(en)
|
2014-07-30 |
2020-05-06 |
Genome Protection, Inc. |
Flagellin compositions and uses
|
|
US10231651B2
(en)
|
2014-09-25 |
2019-03-19 |
Bae Systems Information And Electronic Systems Integration Inc. |
Gait authentication system and method thereof
|
|
US10058253B2
(en)
|
2014-11-11 |
2018-08-28 |
Zenmark, Llc |
System, method, and article for heart rate variability monitoring
|
|
EP3268086A4
(en)
|
2015-03-10 |
2018-11-07 |
Eleusis Benefit Corporation, PBC |
Lsd for the treatment of alzheimer's disease
|
|
WO2016153012A1
(ja)
|
2015-03-24 |
2016-09-29 |
協和発酵キリン株式会社 |
核酸含有脂質ナノ粒子
|
|
US10254298B1
(en)
|
2015-03-25 |
2019-04-09 |
National Technology & Engineering Solutions Of Sandia, Llc |
Detection of metabolites for controlled substances
|
|
ES2882588T3
(es)
|
2015-03-31 |
2021-12-02 |
Turtle Bear Holdings Llc |
Actividad antiviral de setas medicinales y sus constituyentes activos
|
|
HUE047169T2
(hu)
|
2015-04-27 |
2020-04-28 |
Arena Pharm Inc |
5-HT2C receptor agonisták és készítmények és felhasználási eljárások
|
|
CN107073293A
(zh)
|
2015-05-01 |
2017-08-18 |
托匹泰克以色列制药有限公司 |
用于治疗鼻出血的组合物
|
|
WO2016187277A1
(en)
|
2015-05-19 |
2016-11-24 |
Joseph Robert Knight |
Method for isolation of alkaloids and amino acids, and compositions containing isolated alkaloids and amino acids
|
|
US20180147142A1
(en)
|
2015-05-19 |
2018-05-31 |
Joseph Robert Knight |
Method for isolation of alkaloids and amino acids, and compositions containing isolated alkaloids and amino acids
|
|
US9737759B2
(en)
|
2015-07-17 |
2017-08-22 |
Genesant Technologies, Inc. |
Automatic application-based exercise tracking system and method
|
|
JP6789578B2
(ja)
|
2015-07-31 |
2020-11-25 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
５−ｈｔ２ｃ受容体アゴニストおよび組成物、ならびに使用方法
|
|
US9614734B1
(en)
|
2015-09-10 |
2017-04-04 |
Pearson Education, Inc. |
Mobile device session analyzer
|
|
US20180021326A1
(en)
|
2016-07-23 |
2018-01-25 |
Paul Edward Stamets |
Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin
|
|
US20210069170A1
(en)
|
2016-07-23 |
2021-03-11 |
Paul Edward Stamets |
Tryptamine compositions for enhancing neurite outgrowth
|
|
CA3033142A1
(en)
|
2016-08-19 |
2018-02-22 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
US10596378B2
(en)
|
2016-10-18 |
2020-03-24 |
Joseph Rustick |
Method for treatment of depression using synaptic pathway training
|
|
US20180195455A1
(en)
|
2017-01-12 |
2018-07-12 |
GM Global Technology Operations LLC |
Engine combustion phasing control during transient state
|
|
NL2018190B1
(en)
|
2017-01-18 |
2018-07-26 |
Procare Beheer B V |
Psilocybin or psilocin in combination with cannabinoid
|
|
EP3576755B1
(en)
|
2017-02-02 |
2026-07-01 |
McMaster University |
BICARBONATE AS AN ANTIMICROBIAL ENHANCER
|
|
US20190142851A1
(en)
|
2017-11-16 |
2019-05-16 |
CaaMTech, LLC |
Compositions comprising a psilocybin derivative and a cannabinoid
|
|
WO2018145219A1
(es)
|
2017-02-09 |
2018-08-16 |
Serani Mostazal Jorge |
Composición farmaceutica para la prevención y tratamiento de las adicciones a traves de un contracondicionamiento aversivo
|
|
JP7273731B2
(ja)
|
2017-02-09 |
2023-05-15 |
カームテック、エルエルシー |
シロシビン誘導体を含む組成物及び方法
|
|
CN108619214A
(zh)
|
2017-03-15 |
2018-10-09 |
王慎君 |
一种治疗肿瘤的药物
|
|
CA3057994A1
(en)
|
2017-03-30 |
2018-10-04 |
Ojai Energetics Pbc |
A unit dose or mixture comprising carboxylated and decarboxylated cannabinoids
|
|
AU2017408099A1
(en)
|
2017-04-07 |
2019-11-07 |
ACEA Therapeutics, Inc. |
Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same
|
|
US20200147038A1
(en)
|
2017-04-20 |
2020-05-14 |
Eleusis Benefit Corporation, Pbc |
Assessing and treating psychedelic-responsive subjects
|
|
US20180343812A1
(en)
|
2017-05-31 |
2018-12-06 |
Insectergy, Llc |
Cannabis farming systems and methods
|
|
US20190246591A1
(en)
|
2017-05-31 |
2019-08-15 |
Insectergy, Llc |
Insect and cannabis production systems and methods
|
|
JP2020522693A
(ja)
|
2017-06-02 |
2020-07-30 |
ノースウェスタン ユニヴァーシティＮｏｒｔｈｗｅｓｔｅｒｎ Ｕｎｉｖｅｒｓｉｔｙ |
汗の中の注目する標的の検出および分析のための薄い軟質皮膚装着マイクロ流体ネットワーク
|
|
CN107252080A
(zh)
|
2017-07-12 |
2017-10-17 |
沈建国 |
一种麻菇酱油的配方
|
|
GB2571696B
(en)
|
2017-10-09 |
2020-05-27 |
Compass Pathways Ltd |
Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
|
|
WO2019079742A1
(en)
|
2017-10-19 |
2019-04-25 |
Eleusis Benefit Corporation, Pbc |
METHODS AND SYSTEMS FOR IMPROVING THE SAFETY OF PSYCHEDELIC PHARMACOTHERAPIES
|
|
US11723894B2
(en)
|
2017-10-26 |
2023-08-15 |
Terran Biosciences, Inc. |
Combination product for the treatment of neurological and/or psychiatric disorders
|
|
US10703325B2
(en)
|
2017-11-27 |
2020-07-07 |
Autoliv Asp, Inc. |
Multi-chambered side airbag assemblies
|
|
JP2021505649A
(ja)
|
2017-12-04 |
2021-02-18 |
ルクーター デイビッド |
肝内皮細胞のフェネストレーションを調節するための組成物および方法
|
|
FI128750B
(en)
|
2017-12-21 |
2020-11-30 |
Helsingin Yliopisto |
Methods for determining the therapeutic effect of fast-acting antidepressants and related individual antidepressant therapy
|
|
US20190224277A1
(en)
|
2018-01-22 |
2019-07-25 |
CyPhi LLC |
Bio-mimetic formulation
|
|
WO2019161050A1
(en)
|
2018-02-18 |
2019-08-22 |
Akili Interactive Labs, Inc. |
Cognitive platform including computerized elements coupled with a therapy for mood disorder
|
|
JP2021514682A
(ja)
|
2018-03-08 |
2021-06-17 |
ニュー アトラス バイオテクノロジーズ エルエルシー |
トリプタミンの生産方法
|
|
FI129102B
(en)
|
2018-03-19 |
2021-07-15 |
Teknologian Tutkimuskeskus Vtt Oy |
Heterological production of psilosybin
|
|
CN118121577A
(zh)
|
2018-05-04 |
2024-06-04 |
感知神经科学公司 |
治疗物质滥用的方法
|
|
EP3813810A4
(en)
|
2018-06-21 |
2022-03-30 |
Robert John Petcavich |
METHODS OF INDUCING DENDRITICAL AND SYNAPTIC GENESIS IN CHRONIC NEURODEGENERATIVE DISEASES
|
|
WO2020024060A1
(en)
|
2018-08-01 |
2020-02-06 |
Mcmaster University |
Methods for inhibiting microbe growth
|
|
US12090145B2
(en)
|
2018-08-20 |
2024-09-17 |
Yale University |
Combination therapy for treating or preventing depression or other mood diseases
|
|
WO2020053196A1
(en)
|
2018-09-10 |
2020-03-19 |
Universität Basel |
Method for the biocatalytic alkylation of a substrate
|
|
CA3125439A1
(en)
|
2019-01-04 |
2020-07-09 |
Apollo Neuroscience, Inc. |
Systems and methods of wave generation for transcutaneous vibration
|
|
MX2021009037A
(es)
|
2019-01-30 |
2021-10-13 |
Diamond Therapeutics Inc |
Composiciones y metodos para el manejo de trastornos.
|
|
HUE066828T2
(hu)
|
2019-02-22 |
2024-09-28 |
Gh Res Ireland Limited |
5-Metoxi-N,N-Dimetiltriptamin (5-Meo-Dmt) súlyos depressziós rendellenesség kezelésére
|
|
KR20220008824A
(ko)
*
|
2019-04-17 |
2022-01-21 |
컴퍼스 패쓰파인더 리미티드 |
실로시빈으로 불안 장애, 두통 장애 및 섭식 장애를 치료하는 방법
|
|
US20210015738A1
(en)
|
2019-07-17 |
2021-01-21 |
Concept Matrix Solutions |
Oral dissolvable film containing psychedelic compound
|
|
US11766445B2
(en)
|
2019-07-18 |
2023-09-26 |
Concept Matrix Solutions |
Oral soft gel capsule containing psychedelic compound
|
|
US20230277568A1
(en)
|
2020-07-10 |
2023-09-07 |
Eleusis Therapeutics Us, Inc. |
Method of treatment for psilocybin or psilocin infusion
|
|
EP4009026B1
(en)
|
2020-12-02 |
2024-09-18 |
Volvo Truck Corporation |
An air-actuated vehicle system and a method of detecting leakage in an air-actuated vehicle system
|
|
MX2023011326A
(es)
|
2021-03-30 |
2023-10-03 |
Compass Pathfinder Ltd |
Composiciones de psilocibina, metodos para prepararlas y metodos de uso de estas.
|
|
WO2023086252A1
(en)
|
2021-11-09 |
2023-05-19 |
Compass Pathfinder Limited |
Treatment of treatment resistant depression with psilocybin
|
|
WO2024026573A1
(en)
|
2022-08-05 |
2024-02-08 |
Mindset Pharma Inc. |
3-ethylamino-indole dimers as serotonergic agents useful for the treatment of disorders related thereto
|